SCHEMBL6955077

SCHEMBL6955077

CSC(=C(C#N)C#N)N1CCc2ccccc2CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 1/20 0.42
PHGDH O43175 1/20 0.41
MGLL Q99685 1/20 0.41
KMT2A Q03164 2/20 0.40
MAOA P21397 3/20 0.39
TMPRSS2 O15393 1/20 0.39
HTR1A P08908 1/20 0.39
ADRA2A P08913 1/20 0.39
CYP2D6 P10635 1/20 0.39
SLC6A2 P23975 1/20 0.39
MAPT P10636 2/20 0.38
TAAR1 Q96RJ0 2/20 0.38
MEN1 O00255 1/20 0.38
TAS1R3 Q7RTX0 2/20 0.38
TAS1R1 Q7RTX1 2/20 0.38
TAS1R2 Q8TE23 2/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
MAOB P27338 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6952672 0.75 MEN1 (0.44) NOTUMKMT2AMAPTMEN1RAB9A
SCHEMBL6952675 0.75 MEN1 (0.44) NOTUMKMT2AMAPTMEN1RAB9A
SCHEMBL14422106 0.73 ALDH1A1 (0.35) PHGDHMGLLKMT2AMAPTMEN1
SCHEMBL4389325 0.72 USP30 (0.37) MAOAMAPTMAOBHTT
SCHEMBL6187561 0.70 ALDH1A1 (0.36) PHGDHMGLLKMT2AMAPTMEN1
SCHEMBL23630335 0.67 CA12 (0.50) PHGDHCYP2D6MAPTTP53ALDH1A1
SCHEMBL23630440 0.65 LIPE (0.42) DRD2DRD1DRD4DRD5DRD3
SCHEMBL19660223 0.65 NOTUM (0.54) NOTUMPHGDHMGLLKMT2AMAOA
SCHEMBL249471 0.64 NOTUM (0.81) NOTUMKMT2AMAPTTAAR1MEN1
SCHEMBL6189015 0.64 USP2 (0.46) KMT2AMAPTMEN1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed